Skip to content

H.R. 2666 · 118th Congress (2023–2025)

Medicaid VBPs for Patients Act

This bill provides statutory authority for regulations that allow for the use of varying best price points under value-based purchasing arrangements for purposes of the Medicaid Drug Rebate Program. (Value-based purchasing arrangements refer to arrangements in which the price of a drug is linked to clinical outcomes; such arrangements are particularly used for new high-cost treatments, such as gene therapies.)

The Government Accountability Office must study the impact of value-based purchasing arrangements on federal health care programs, including with respect to the bill's changes.

Additionally, the bill (1) exempts sales of drugs that are made under value-based purchasing arrangements from calculations of the manufacturer average sales price for purposes of payments under Medicare medical services, if the manufacturer reports multiple best prices under Medicaid in accordance with the bill's changes; and (2) requires the Centers for Medicare & Medicaid Services to establish a program under which state Medicaid programs may cover drugs in inpatient settings via value-based purchasing arrangements.

The bill's changes terminate five years after enactment; any value-based purchasing arrangements that are in effect as of the date of termination continue to apply.

Show official title

To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.

Expired in House committee

Derived from the legislative history, not an official disposition.

Latest actionCommittee discharged

This bill’s path

This is H.R. 2666’s recorded path, not a universal congressional workflow.

How bills become lawAll actions
  1. Introduced

  2. Passed House

  3. Passed Senate

  4. Sent to President

  5. Signed into law

  6. Expired

Sponsor
Rep. Brett Guthrie (R-KY-2)
Cosponsors
42 cosponsors

5 original · 37 later

22 R · 20 D

  1. Rep. Jake Auchincloss (D-MA-4)· Original · Apr 18, 2023
  2. Rep. Anna G. Eshoo (D-CA-16)· Original · Apr 18, 2023
  3. Rep. John Joyce (R-PA-13)· Original · Apr 18, 2023
  4. Rep. Mariannette Miller-Meeks (R-IA-1)· Original · Apr 18, 2023
  5. Rep. Scott H. Peters (D-CA-50)· Original · Apr 18, 2023
  6. Rep. Dan Crenshaw (R-TX-2)· Later · May 11, 2023
  7. Rep. Eric Swalwell (D-CA-14)· Later · May 11, 2023
  8. Rep. Gus M. Bilirakis (R-FL-12)· Later · May 15, 2023
  9. Rep. Neal P. Dunn (R-FL-2)· Later · May 17, 2023
  10. Rep. Troy Balderson (R-OH-12)· Later · May 22, 2023
  11. Rep. Dean Phillips (D-MN-3)· Later · Jun 30, 2023
  12. Rep. Ami Bera (D-CA-6)· Later · Jul 10, 2023
  13. Rep. Ted Lieu (D-CA-36)· Later · Jul 17, 2023
  14. Rep. Mike Thompson (D-CA-4)· Later · Aug 1, 2023
  15. Rep. Mikie Sherrill (D-NJ-11)· Later · Aug 22, 2023
  16. Rep. Chrissy Houlahan (D-PA-6)· Later · Sep 14, 2023
  17. Rep. Earl L. "Buddy" Carter (R-GA-1)· Later · Oct 2, 2023
  18. Rep. Josh Gottheimer (D-NJ-5)· Later · Nov 1, 2023
  19. Rep. Troy A. Carter (D-LA-2)· Later · Nov 6, 2023
  20. Rep. A. Drew Ferguson IV (R-GA-3)· Later · Nov 7, 2023
  21. Rep. Jared Huffman (D-CA-2)· Later · Nov 14, 2023
  22. Rep. Kevin Mullin (D-CA-15)· Later · Nov 15, 2023
  23. Rep. Brittany Pettersen (D-CO-7)· Later · Nov 28, 2023
  24. Rep. Josh Harder (D-CA-9)· Later · Dec 5, 2023
  25. Rep. Larry Bucshon (R-IN-8)· Later · Dec 12, 2023
  26. Rep. Donald G. Davis (D-NC-1)· Later · Dec 12, 2023
  27. Rep. Michael C. Burgess (R-TX-26)· Later · Dec 14, 2023
  28. Rep. Glenn Ivey (D-MD-4)· Later · Dec 22, 2023
  29. Rep. Mike Kelly (R-PA-16)· Later · Jan 3, 2024
  30. Rep. Austin Scott (R-GA-8)· Later · Jan 11, 2024
  31. Rep. Burgess Owens (R-UT-4)· Later · Jan 31, 2024
  32. Rep. John R. Moolenaar (R-MI-2)· Later · Feb 5, 2024
  33. Rep. Daniel Meuser (R-PA-9)· Later · Feb 5, 2024
  34. Rep. Juan Ciscomani (R-AZ-6)· Later · Feb 9, 2024
  35. Rep. Yadira Caraveo (D-CO-8)· Later · Feb 28, 2024
  36. Rep. Jefferson Van Drew (R-NJ-2)· Later · Apr 9, 2024
  37. Rep. Jeff Duncan (R-SC-3)· Later · Apr 16, 2024
  38. Rep. Nicole Malliotakis (R-NY-11)· Later · Apr 30, 2024
  39. Rep. Michelle Steel (R-CA-45)· Later · Apr 30, 2024
  40. Rep. Kat Cammack (R-FL-3)· Later · Jun 25, 2024
  41. Rep. Beth Van Duyne (R-TX-24)· Later · Jun 25, 2024
  42. Rep. Marilyn Strickland (D-WA-10)· Later · Sep 24, 2024
Policy area
Health
Subjects
  • Administrative law and regulatory procedures
  • Congressional oversight
  • Department of Health and Human Services
  • Government studies and investigations
  • Health care costs and insurance
  • Intergovernmental relations
  • Medicaid
  • Prescription drugs

On this page

Timeline

i

In chronological order. Major procedural acts are shown in full. Committee work and ordinary amendments fold in place where they happened, so they do not jump the sequence or stretch the timeline.

  1. Introduced in House

    Document: Introduced in House

    Sources
  2. Latest
    ▸ 9 committee actions · Apr 18, 2023 – Dec 19, 2024
    1. Referred to committee

      Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

      Sources
    2. Referred to Health

      Referred to the Subcommittee on Health.

      Sources
    3. Subcommittee markup session held

      Subcommittee Consideration and Mark-up Session Held.

      Sources
    4. Forwarded by subcommittee

      Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 16 - 11 .

      Sources
    5. Markup session held

      Committee Consideration and Mark-up Session Held.

      Sources
    6. Ordered reported

      Ordered to be Reported (Amended) by the Yeas and Nays: 31 - 19.

      Sources
    7. Reported by committee

      Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-743, Part I.

      Sources
    8. Referred to Work and Welfare

      Referred to the Subcommittee on Work and Welfare.

      Sources
    9. Committee discharged

      Committee on Ways and Means discharged.

      Sources
  3. Expired

    Introduced → Referred to House committee → Reported by committee → No further action before the 118th Congress ended.

Committees

  1. HouseEnergy and CommerceReferred Apr 18, 2023 · Markup May 24, 2023 · Reported Nov 18, 2024H. Rept. 118-743
    1. May 24, 2023 · Markup

    1. H. Rept. 118-743 · Nov 18, 2024 · Medicaid Vbps for Patients Act
  2. HouseHealthReferred May 15, 2023 · Markup May 17, 2023 · Reported May 17, 2023
    1. May 17, 2023 · Meeting

    2. Apr 26, 2023 · Hearing

  3. HouseWays and MeansReferred Apr 18, 2023
  4. HouseWork and WelfareReferred Dec 17, 2024

Text & titles

i

Each distinct name Congress.gov recorded, once. Official, short, display, and popular titles stay distinct when the wording differs. The same wording is not repeated for every text version.

Text versions
VersionDateLinks
Introduced in House
Reported in House
Titles (3)
  1. Medicaid VBPs for Patients Act

    Display title, Short title · Reported in House, Introduced in House

  2. MVP Act

    Short title · Introduced in House

  3. To amend title XIX of the Social Security Act to codify value-based purchasing arrangements under the Medicaid program and reforms related to price reporting under such arrangements, and for other purposes.

    Official title · Introduced in House